Fallah J, Xu J, Weinstock C, Brave MH, et al. FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol 2023 Dec 21:JCO2301868. doi: 10.1200/JCO.23.01868.
PMID: 38127780